ישראל -
עברית -
Ministry of Health
ארנספ 300 מקג
amgen europe b.v. - darbepoetin alfa - תמיסה להזרקה - darbepoetin alfa 300 mcg / 0.6 ml - darbepoetin alfa
ישראל -
עברית -
Ministry of Health
ארנספ 500 מקג
amgen europe b.v. - darbepoetin alfa - תמיסה להזרקה - darbepoetin alfa 500 mcg/ml - darbepoetin alfa
ישראל -
עברית -
Ministry of Health
אראנספ 80 מקג
amgen europe b.v. - darbepoetin alfa - תמיסה להזרקה - darbepoetin alfa 80 mcg / 0.4 ml - darbepoetin alfa
ישראל -
עברית -
Ministry of Health
קסנפוזיים
sanofi israel ltd - olipudase alfa - olipudase alfa 20 mg/vial - olipudase alfa
ישראל -
עברית -
Ministry of Health
אולסניק
teva pharmaceutical indust.ltd - sucralfate 1000 mg - tablets - sucralfate - ulsanic is indicated in the short-term treatment of duodenal ulcer and gastric ulcer.
ישראל -
עברית -
Ministry of Health
אלפא די 3 0.5 מק"ג
teva pharmaceutical indust.ltd - alfacalcidol 0.5 mcg - capsules - alfacalcidol - renal bone disease . hypoparathyroidisim. rickets and osteomalacia. osteoporosis. primary and tertiary hyperparathyroidism. neonatal hypocalcemia.
ישראל -
עברית -
Ministry of Health
אינפסורף
rafa laboratories ltd - calfactant as phospholipid - תרחיף - calfactant as phospholipid 35 mg/ml - lung surfactants - infasurf is indicated for the prevention of respiratory distress syndrome (rds) in premature infants at high risk for rds and for the treatment ("rescue") of premature infants who develop rds. infasurf decreases the incidence of rds mortality due to rds and air leaks associated with rds. prophylaxis : prophylaxis therapy at birth with infasurf is indicated for premature infants <29 weeks of gestational age at significant risk for rds. infasurf prophylaxis should be administered as soon as possible preferably within 30 minutes after birth. treatment: infasurf therapy is indicated for infants 72 hours of age with rds (confirmed by clinical and radiologic findings) and requiring endotracheal intubation.
ישראל -
עברית -
Ministry of Health
bellacontour
alfatech medical systems - אחר - מערכת לחיטוב הגוף הצרת היקפיים צמצום והעלמת צלוליט שיפור מרקם העור
ישראל -
עברית -
Ministry of Health
קסינתה 500 יחבל
pfizer pharmaceuticals israel ltd - moroctocog alfa - אבקה מיובשת בהקפאה להזרקה - moroctocog alfa 500 iu/vial - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency)
ישראל -
עברית -
Ministry of Health
קסינתה 1000 יחבל
pfizer pharmaceuticals israel ltd - moroctocog alfa - אבקה וממס להכנת תמיסה להזרקה - moroctocog alfa 1000 iu/vial - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency)